Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
| Excerpt | Reference |
|---|
| "Mild hyperthyroidism is not a hazard to an otherwise normal pregnancy and does not require therapy on the basis of this presumption." | ( Prout, TE, 1975) |
| "The hyperthyroidism is self-limiting and should be treated conservatively." | ( Daly, R; Woolf, PD, 1976) |
| "Hyperthyroidism is generally considered to be ameliorated during pregnancy, and there appears to be a high incidence of postpartum exacerbation." | ( Petersen, S; Serup, J, 1977) |
| "As iodine-induced hyperthyroidism is often resistant to the usual antithyroid treatment, thyroid function should be checked whenever the use of iodine-containing contrast media is indicated." | ( Herrmann, J; Krüskemper, HL, 1978) |
| "Hyperthyroidism is a clinically dramatic but usually benign syndrome that is most commonly associated with the clinical triad known as Graves' disease." | ( Larsen, PR, 1976) |
| "A patient with hyperthyroidism is described who developed grand mal seizures when anth-thyroid medication was withdrawn." | ( Bechar, M; Korczyn, AD, 1976) |
| "Hyperthyroidism is a common, self-limited finding in hyperemesis." | ( Goodwin, TM; Mestman, JH; Montoro, M, 1992) |
| "Thus, hyperthyroidism is one of the diseases in which serum concentrations of 7 S collagen are increased." | ( Goto, H; Misaki, M; Shima, T; Yano, Y, 1992) |
| "Hyperthyroidism is invariably accompanied by nervous system dysfunctions." | ( Battistella, PA; Casara, GL; Pellegrino, PA; Pozzan, GB; Rigon, F; Zacchello, F; Zancan, L, 1992) |
| "Neonatal hyperthyroidism is only seen in children whose mothers had an autoimmune thyroid disease." | ( Bovero, G; Martin Laval, A; Mouroux, D; Nicolino, J, 1991) |
| "Hyperthyroidism is accompanied by significant dysfunction of both proximal and distal skeletal muscles." | ( Benner, R; Burdett, R; Klein, I; Levey, GS; Olson, BR; Trzepacz, P, 1991) |
| "The cases of hyperthyroidism are transitory, in the course moderate and concern only already preformed, so-called latent form." | ( Bauch, K; Hänsgen, K; Klaua, M; Ulrich, FE, 1991) |
| "Hyperthyroidism is associated with a marked effect on the cardiovascular system." | ( Klein, I; Mintz, G; Pizzarello, R, 1991) |
| "Thus, hyperthyroidism is unaccompanied by and significant changes in the coupling of mitochondrial creatine kinase with oxidative phosphorylation." | ( Kadaia, AI; Kallikorm, AP; Saks, VA; Seppet, EK, 1990) |
| "The nature of hyperthyroidism is briefly analysed, as it has direct relevance to the integral psychiatric manifestations of the disorder." | ( Jadresic, DP, 1990) |
| "Hyperthyroidism is difficult to diagnose in the elderly because at this age thyroid disorders are often insidious and atypical with non-specific symptoms." | ( Ansaldi, E; Berni, P; Farias, M; Malvicino, F; Scaglione, L, 1989) |
| "Hyperthyroidism is associated with negative calcium balance, normal to increased serum calcium concentrations, and decreased cortical bone mass." | ( Nussbaum, SR; Ross, DS, 1989) |
| "Hyperthyroidism is frequently associated with myopathy." | ( Angerås, U; Hasselgren, PO; Oldfors, A, 1986) |
| "Furthermore, hyperthyroidism is associated with a specific increase in ventricular ANF mRNA expression as has been observed in other conditions causing ventricular hypertrophy." | ( Bloch, KD; Ladenson, PW; Seidman, JG, 1988) |
| "20 cases of feline hyperthyroidism are reported." | ( Kraft, W, 1988) |
| "Hyperthyroidism is usually controlled initially by antithyroid drugs, such as carbimazole, which interfere with the synthesis of thyroid hormone." | ( Campbell, AJ, 1986) |
| "Hyperthyroidism is known to further impair carbohydrate metabolism in diabetic patients." | ( Bratusch-Marrain, PR; Komjati, M; Waldhäusl, WK, 1985) |
| "Post-traumatic hyperthyroidism is discussed." | ( Banssillon, V; Doussin, JF; Dubost, J, 1985) |
| "Thus, hyperthyroidism is considered to be one of the diseases in which S-ACE is elevated." | ( Hirata, Y; Ishii, M; Kimura, K; Murao, S; Nakamura, Y; Nishiyama, K; Takeda, T; Yamakada, M, 1982) |
| "The hyperthyroidism is usually treated with beta-blockers and antithyroid thionamide drugs, although reinstitution of iodine to block thyroid hormone release or corticosteroids occasionally may be necessary." | ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Hyperthyroidism is associated with degradation of carbohydrate metabolism." | ( Aubertin, J; Brunel, PG; David, JP; Gin, H; Manciet, G; Rivière, L; Roger, P, 1984) |
| "T3-hyperthyroidism is described by high values of these ratios." | ( Grau, R; Keck, FS; Loos, U, 1984) |
| "Hyperthyroidism is associated with increased serum T4, T3, and free T4." | ( Surks, MI, 1981) |
| "We conclude that hyperthyroidism is characterized by 1) increased glucose turnover and hyperglucagonemia in the basal state, 2) a reduced glucemic response to physiological infusions of epinephrine and glucagon, 3) a sustained response of glucose production to epinephrine and glucagon, and 4) the lack of epinephrine-induced suppression of glucose clearance, presumably due to an exaggerated response of insulin secretion to epinephrine." | ( Covelli, A; Lombardi, G; Morrone, G; Perez, G; Rossi, R; Scopacasa, F; Ungaro, B, 1980) |
| "Hyperthyroidism is a rare side effect of amiodarone treatment." | ( Grenadier, E; Keidar, S; Palant, A, 1980) |
| "Hyperthyroidism is associated with an impairment of growth hormone (GH) responses to secretagogues." | ( Cho, JH; Huh, KB; Kim, KR; Lee, EJ; Lee, HC; Lim, SK; Nam, MS; Nam, SY; Song, YD, 1995) |
| "Hyperthyroidism is a risk factor for osteoporosis, but the relative contributions of the episode of hyperthyroidism and thyroxine replacement for subsequent hyperthyroidism remain uncertain." | ( Grant, DJ; McMurdo, ME; Mole, PA; Paterson, CR, 1995) |
| "Hyperthyroidism is associated with exercise intolerance." | ( Laughlin, MH; McAllister, RM; Sansone, JC, 1995) |
| "Reports of hyperthyroidism are rare and it is less well known among patients treated with lithium." | ( Forbath, N; Merskey, H; Persad, E, 1993) |
| "Hyperthyroidism is associated with altered GH secretion." | ( Casanueva, F; Dieguez, C; Muruais, C; Portioli, I; Valcavi, R; Zini, M, 1993) |
| "Hyperthyroidism is associated with increased serum IGF-I levels and marked alterations in the neuroregulation of GH secretion." | ( Casanueva, F; Dieguez, C; Muruais, C; Portioli, I; Valcavi, R; Zini, M, 1993) |
| "A woman treated for hyperthyroidism is described." | ( Bergmann, P; Karmali, R; Mirkine, N, 1993) |
| "Hyperthyroidism is often associated with behavioral disorders, and thyroid hormones modify receptor sensitivity as well as the synthesis and/or turnover rate of many neurotransmitters." | ( Bertolini, A; Ottani, A; Sandrini, M; Vergoni, AV; Vitale, G, 1996) |
| "Untreated hyperthyroidism is characterized by increased bone turnover with loss of bone and bone mineral." | ( Charles, P; Eriksen, EF; Langdahl, BL; Loft, AG; Mosekilde, L, 1996) |
| "In contrast, hyperthyroidism is associated with decreased total and HDL cholesterol, total/HDL cholesterol ratio, and apo AI levels." | ( Hay, ID; Hodge, D; Katz, K; Kottke, BA; Nguyen, TT; O'Brien, T, 1997) |
| "Hyperthyroidism is frequently associated with changes in liver functions." | ( Fischer, MR; Gärtner, R; Huss, R; Spes, CH, 1997) |
| "We conclude that hyperthyroidism is primarily accompanied by quantitative as well as qualitative changes in the lean body while considerable fat increase is the most important feature of hypothyroidism." | ( Kosel, A; Schlaghecke, R; Seppel, T, 1997) |
| "Cats with severe hyperthyroidism are less likely to respond to ipodate than are cats with mild or moderate disease, and cats in which serum T3 concentration does not return to the reference range are unlikely to have an adequate improvement in clinical signs." | ( Murray, LA; Peterson, ME, 1997) |
| "Hyperthyroidism is associated with elevated plasma levels of endothelium-derived proteins such as von Willebrand factor (vWF), fibronectin (FN) and endothelin-1 (ET-1)." | ( Baumgartner-Parzer, SM; Brunner, M; Müller, M; Nowotny, P; Reining, G; Sexl, V; Wagner, L; Waldhäusl, W, 1997) |
| "Active hyperthyroidism is associated with reduced bone mass." | ( Escobar-Jiménez, F; Jódar Gimeno, E; Luna del Castillo, JD; Muñoz-Torres, M; Oleà, N; Quesada Charneco, M, 1997) |
| "Congenital hyperthyroidism is a rare, transient disease usually caused by transmission of thyrotropin receptor autoantibodies from the mother with Graves' disease to her child." | ( Broecker, M; Derwahl, M; Gerlich, M; Lohse, MJ; Schwab, KO; Söhlemann, P, 1997) |
| "Hyperthyroidism is the most common disorder of the thyroid." | ( Scripture, DL, 1998) |
| "Hyperthyroidism is associated with a reduction in bone mineral density (BMD)." | ( Ammari, F; Evans, WD; Hanna, FW; Lazarus, JH; Pettit, RJ; Sandeman, D, 1998) |
| "Hyperthyroidism is a reason for immediately suspending treatment for 90% of the cardiologists, only 5% would continue and 16% would prescribe antithyroid drugs." | ( Binz, K; Burger, A; Vallotton, MB, 1998) |
| "Iodine-induced hyperthyroidism is rare and is usually encountered in patients with a pre-existent autonomous thyroid function." | ( Blom, DM; Lips, P; Strack van Schijndel, RJ; van Guldener, C, 1998) |
| "Subclinical hyperthyroidism is a symptomatic or asymptomatic condition with an absent response of thyrotropin (TSH) to thyrotropin-releasing hormone in the presence of normal serum levels of thyroid hormones for the general population, though supraoptimal for the individual." | ( Angellotti, G; Biondi, B; Bonè, F; Cittadini, A; Fazio, S; Lombardi, G; Palmieri, EA; Riccio, G; Saccà, L; Tremalaterra, R, 1999) |
| "Hyperthyroidism is associated with reduced bone mineral density." | ( Engler, H; Oettli, RE; Riesen, WF, 1999) |
| "The hyperthyroidism is caused by autonomous nodular growth and function of the thyroid gland and it is accompanied by a high frequency of goiter." | ( Andersen, S; Bülow Pedersen, I; Hreidarsson, AB; Jørgensen, T; Knudsen, N; Laurberg, P; Nøhr, SB; Ovesen, L; Pedersen, KM; Perrild, H, 2000) |
| "Hyperthyroidism is associated with enhanced osteoblastic and osteoclastic activity, and patients frequently have low bone mineral density and high bone turnover." | ( Aimo, G; Ardissone, P; Gallone, G; Gola, D; Isaia, GC; Mussetta, M; Roggia, C; Stefano, MD, 2000) |
| "Hyperthyroidism is more common than hypothyroidism and may be explained by increased iodine intake." | ( Baudusseau, O; Dupuis, JM; Geslin, P; Rouleau, F; Victor, J, 2001) |
| "Hyperthyroidism is associated with a higher incidence of arterial thromboembolism; increasing age, atrial fibrillation, and mitral valve abnormalities are risk factors." | ( Burggraaf, J; Cohen, AF; de Meyer, PH; Emeis, JJ; Lalezari, S; Pijl, H; Vischer, UM, 2001) |
| "Subclinical hyperthyroidism is defined as suppressed serum sensitive thyrotropin (TSH) and normal serum thyroxine and triiodothyronine levels." | ( Fatourechi, V, 2001) |
| "Iodine induced hyperthyroidism is frequently observed in patients affected by euthyroid iodine deficient goiter when suddenly exposed to excess iodine." | ( Roti, E; Uberti, ED, 2001) |
| "Hyperthyroidism is associated with enhanced systolic function." | ( Jonderko, G; Kucharz, EJ; Marcisz, C; Wojewódka, J, 2001) |
| "Subclinical hyperthyroidism is characterised by reduced serum TSH levels despite free thyroxine (T4) and tri-iodothyronine (T3) estimates within the reference range, in subjects with no obvious symptoms of hyperthyroidism." | ( Faber, J; Mehlsen, J; Schifter, S; Wiinberg, N, 2001) |
| "Hyperthyroidism is an important etiology of paroxysmal atrial fibrillation (AF)." | ( Chan, P; Chang, MS; Chen, SA; Chen, YC; Chen, YJ; Lin, CI, 2002) |
| "Hyperthyroidism is an exceptionally rare finding." | ( Abdallah-Matta, MP; Caron, P; Dubarry, PH; Pessey, JJ, 2002) |
| "Subclinical hyperthyroidism is more prevalent in the iodine deficient area than in the severe iodine excessive area." | ( Chen, W; Cui, B; Guan, H; Hu, F; Jin, Y; Li, Y; Shan, Z; Shi, X; Teng, W; Tong, Y; Wang, Z; Yang, F; Yang, S; Yuan, B, 2002) |
| "Subclinical hyperthyroidism is characterized by a clearly low serum concentration of thyrotropin (TSH) and the absence of obvious symptoms of hyperthyroidism." | ( Sawin, CT, 2002) |
| "Hyperthyroidism is characterized by increased levels of circulating free fatty acids (FFA) and increased lipid oxidation, but it is uncertain which regional fat depots contribute." | ( Djurhuus, CB; Gravholt, CH; Jørgensen, JO; Møller, N; Nørrelund, H; Riis, AL; Weeke, J, 2002) |
| "Hyperthyroidism is an established risk factor for osteoporosis." | ( Cheng, SY; Harvey, CB; Kaneshige, K; Kaneshige, M; O'Shea, PJ; Suzuki, H; Williams, GR, 2003) |
| "Subclinical hyperthyroidism is associated with atrial fibrillation, osteoporosis and dementia." | ( Corssmit, EP; Wiersinga, WM, 2003) |
| "Hyperthyroidism is classically manifested by signs of hypercatabolism." | ( Bergheul, S; Brinkane, A; Crickx, L; Levy, R, 2003) |
| "Hyperthyroidism is associated with oxidative stress." | ( Bobby, Z; Goswami, K; Koner, BC; Nandakumar, DN; Sen, SK, 2003) |
| "Hyperthyroidism is known to affect multiple organ functions, and thyroid hormone has been known to improve myocardial function in a failing heart." | ( Itoh, K; Kitamura, N; Minakawa, M; Murakami, A; Odagiri, S; Otaki, M; Takeuchi, K; Yaku, H, 2003) |
| "Hyperthyroidism is a hypermetabolic state accompanied by increased oxygen utilization, increased production of reactive oxygen species and consequentially measurable changes in antioxidative factors." | ( Bacić-Vrca, V; Cepelak, I; Kirin, M; Mayer, L; Romić, Z; Skreb, F; Zanić-Grubisić, T, 2004) |
| "Hyperthyroidism is characterized by increased bone turnover and resorptive activity." | ( Aydin, S; Karter, Y; Simsek, G; Uzun, H, 2003) |
| "Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Hyperthyroidism is a rare complication." | ( Law, A; Lipton, JH; Rifkind, J; Rosen, F, 2004) |
| "Hyperthyroidism is characterized by accelerated bone turnover, caused from direct stimulation of bone cells by increased thyroid hormones." | ( Atay, A; Barsal, G; Erciyas, F; Hekimsoy, Z; Taneli, F, 2004) |
| "Hyperthyroidism is an uncommon, but previously reported cause of persistent vomiting." | ( Cools, BM; Hoogendoorn, EH, 2004) |
| "Central hyperthyroidism is mainly due to two different causes, TSH-secreting pituitary adenoma (TSH-oma) and resistance to thyroid hormone in its pituitary variant, i." | ( Beck-Peccoz, P; Facchetti, M; Fugazzola, L; Mannavola, D; Persani, L; Vannucchi, G; Verga, U; Zanardelli, M, 2005) |
| "Hyperthyroidism is associated with an increase in myocardial oxygen consumption that, due to an imbalance of oxygen demand and supply, can cause angina." | ( Lai, WT; Lin, TH; Sheu, SH; Su, HM; Voon, WC, 2005) |
| "Hyperthyroidism is associated with increased psychiatric morbidity." | ( Fukui, K; Kitabayashi, Y; Narumoto, J; Oka, S; Shimizu, H; Sumi, M; Ueda, H, 2005) |
| "Hyperthyroidism is of two types." | ( Thomopoulos, P, 2005) |
| "Hyperthyroidism is associated with various movement disorders, such as chorea and tremors." | ( Lim, EC; Teoh, HL, 2005) |
| "Hyperthyroidism is associated with low exercise tolerance despite high cardiac output and sometimes with the development of heart failure." | ( Aizawa, Y; Chinushi, M; Hatada, K; Hosaka, Y; Komura, S; Ma, M; Washizuka, T; Watanabe, H; Watanabe, K; Yamamoto, T; Yoshida, T, 2005) |
| "Hyperthyroidism is in a sympathovagal imbalanced state, characterized by both increased sympathetic and decreased vagal modulation of the heart rate." | ( Chen, JL; Chiu, HW; Chu, WC; Tseng, YJ, 2006) |
| "Incidence of the hyperthyroidism is continuously increasing, whereas our knowledge concerning the facilitating or etiologic factors of this increase are still partial." | ( Bidingija, M; Buzzetti, R; Ditu, M; Galgani, A, 2006) |
| "Overt hyperthyroidism is associated with recognized cardiovascular effects believed to be reversed by antithyroid therapy; however, increasing data suggest significant long-term cardiovascular mortality." | ( Franklyn, JA; Gammage, MD; Holder, RL; Osman, F; Sheppard, MC, 2007) |
| "Sub-clinical hyperthyroidism is not associated with CHD or mortality from cardiovascular causes." | ( Arora, R; Barsano, CP; Duggal, J; Maldonado, F; Molnar, J; Singh, S, 2008) |
| "Subclinical hyperthyroidism is characterized by low circulating TSH concentrations, together with normal concentrations of free T4 and free T3." | ( Franklyn, JA, 2007) |
| "Hyperthyroidism is a common disease in the elderly." | ( Anastasopoulou, C; Goldberg, TH; Moyer, S; Ramos-Bonner, LS, 2007) |
| "Hyperthyroidism is a common endocrinopathy of older cats and is associated with an increased glomerular filtration rate (gfr)." | ( Boag, AK; Church, DB; Haller, M; Neiger, R; Slater, L; Stevens, KB, 2007) |
| "Hyperthyroidism is associated with an increased supraventricular ectopic activity in patients with normal hearts." | ( Burow, A; Chappuis, B; Delacrétaz, E; Diem, P; Kucera, JP; Stuber, T; Wustmann, K; Zanchi, A, 2008) |
| "Hypothyroidism and hyperthyroidism are commonly present conditions in adults, leading to neurological symptoms, affecting the central and peripheral nervous system, and to neurocognitive impairment." | ( Fodale, V; Mafrica, F, 2008) |
| "Hyperthyroidism is more prevalent in patients with DS than in the general population and has no gender predominance." | ( Cano-Pérez, JF; Cerda-Esteva, M; Chillaron-Jordan, JJ; Corretger, JM; Flores-Le-Roux, JA; Goday-Arno, A, 2009) |
| "Hyperthyroidism is a pathological condition characterized by an altered autonomic cardiovascular control, resulting in an increase of the sympathetic and a decrease of the parasympathetic modulation of heart rate variability." | ( Bevilacqua, M; Bulgheroni, M; Montano, N; Muratori, M; Pecis, M; Porta, A; Tobaldini, E, 2008) |
| "Although transient hyperthyroidism is widely thought to be causative of a hyperemesis during pregnancy, this case report with a mildly hypothyroidism emphasizes that there might be other, yet unknown, factors that can cause such a severe complication." | ( Blankenstein, TJ; Friese, K; Kainer, F; Mylonas, I, 2009) |
| "Hypothyroidism and hyperthyroidism are known to affect cholesterol metabolism, bile acid synthesis and bile content." | ( Bozkurt, S; Cakir, M; Kayacetin, E; Toy, H, 2009) |
| "Graves'-like hyperthyroidism is induced by immunizing BALB/c mice with adenovirus expressing the thyrotropin receptor (TSHR) or its A-subunit." | ( Aliesky, HA; McLachlan, SM; Misharin, AV; Mizutori, Y; Nagayama, Y; Rapoport, B, 2009) |
| "Hyperthyroidism is characterized by hyperphagia and increased basal metabolic rate." | ( Habeos, I; Kyriazopoulou, V; Metallinos, IC; Psyrogiannis, A; Theodoropoulou, A; Vgenakis, AG, 2009) |
| "But previous hyperthyroidism is independently associated with an increased risk for fracture." | ( Nishikawa, T; Saito, J, 2009) |
| "Hyperthyroidism is characterised by high levels of serum thyroxine and triiodothyronine, and low levels of thyroid-stimulating hormone." | ( Nygaard, B, 2008) |
| "This type of hyperthyroidism is usually de novo and is accompanied by more clinical signs, symptoms, and analytical derangements, as well as higher titres of TRAb at diagnosis than milder forms of hyperthyroidism." | ( Dévora, O; Díez, JJ; García, J; García-Arévalo, C; Iglesias, P; Tajada, P, 2010) |
| "Hyperthyroidism is mainly caused by Graves' disease and toxic adenoma or multinodular goiter." | ( Mann, K; Möller, L, 2010) |
| "TINU syndrome with hyperthyroidism is rare." | ( Fujii, T; Iwamoto, S; Kakei, S; Matsui, N; Tanaka, H; Toda, T, 2010) |
| "Clinical hyperthyroidism is not uncommon in pregnancy, with a reported prevalence of 0." | ( Botto, LD; Cassina, M; Clementi, M; Di Gianantonio, E; Leoncini, E; Mastroiacovo, P, 2010) |
| "Hyperthyroidism is a relative uncommon but important cause of atrial fibrillation." | ( Buccelletti, F; Carroccia, A; Franceschi, F; Gilardi, E; Marsiliani, D; Silveri, NG, 2011) |
| "Hyperthyroidism is present in nearly 10% of new-onset atrial fibrillation." | ( Buccelletti, F; Carroccia, A; Franceschi, F; Gilardi, E; Marsiliani, D; Silveri, NG, 2011) |
| "Hyperthyroidism is prevalent during pregnancy, but little is known about the effects of excess thyroid hormone on the development of embryonic neural stem/progenitor cells (NSCs), and the mechanisms underlying these effects." | ( Chen, C; Chen, S; Li, M; Qu, M; Wang, Y; Wei, A; Xu, S; Yang, X; Yu, Z; Zhang, L; Zhang, Y; Zhong, M; Zhou, Z, 2011) |
| "Hyperthyroidism is a common endocrine disorder affecting 2% of females and 0." | ( Boutzios, G; Christou, M; Diamanti-Kandarakis, E; Economou, F; Karachalios, A; Livadas, S; Palimeri, S; Palioura, H; Xyrafis, X; Zerva, A, 2010) |
| "Neonatal hyperthyroidism is a rare disorder and occurs in two forms." | ( Ağladıoğlu, SY; Aycan, Z; Baş, VN; Cetinkaya, S; Ceylaner, S; Kendirici, HN, 2010) |
| "Hyperthyroidism is characterised by high levels of serum thyroxine and triiodothyronine, and low levels of thyroid-stimulating hormone." | ( Nygaard, B, 2010) |
| "The development of hyperthyroidism is largely influenced by the level of HCG and disease burden, and usually settles with treatment of the persistent GTD." | ( Coleman, RE; Everard, J; Hancock, BW; Walkington, L; Webster, J, 2011) |
| "Subclinical hyperthyroidism is defined by low or undetectable serum thyroid-stimulating hormone levels, with normal free thyroxine and total or free triiodothyronine levels." | ( Braunstein, GD; Donangelo, I, 2011) |
| "Hyperthyroidism is more challenging." | ( Capraro, J; Thalmann, S, 2011) |
| "Subclinical hyperthyroidism is defined as a serum thyrotrophin (TSH) below the reference range but a normal thyroxine (T4) and triiodothyronine (T3) level in a patient who is either asymptomatic or has only non-specific symptoms." | ( Vanderpump, MP, 2011) |
| "When hyperthyroidism is treated, the goals of therapy are to achieve a subclinical hyperthyroid state and monitor fetal development." | ( Mandel, SJ; Rivkees, SA, 2011) |
| "Transient hyperthyroidism is frequent after parathyroidectomy for SHP with Tg being a suitable marker." | ( Grafe, IA; Isermann, B; Kopf, S; Leowardi, C; Nawroth, PP; Reismann, P; Rudofsky, G; Tsioga, M, 2011) |
| "Graves' hyperthyroidism is associated with atherosclerosis as assessed by CIMT." | ( Akdemir, R; Bilir, C; Caliskan, M; Cinemre, H; Gökosmanoglu, F, 2012) |
| "Hyperthyroidism is a questionable risk factor for thromboembolism among patients with atrial fibrillation." | ( Coeli, CM; Duarte, MM; Souza, MV; Vaisman, M, 2012) |
| "Hyperthyroidism is a frequent veterinary problem, particularly in elderly cats." | ( Chapman, SF, 2011) |
| "Hyperthyroidism is associated with a tendency toward hypercoagulation and hyperfibrinolysis." | ( Bohdanowicz-Pawlak, A; Brona, A; Jędrzejuk, D; Milewicz, A, 2011) |
| "Hyperthyroidism is a common side effect encountered in patients prescribed long-term amiodarone therapy for cardiac arrhythmias." | ( Siu, CW; Tse, HF; Wong, SM, 2012) |
| "Subclinical hyperthyroidism is a difficult entity to diagnose because of silent clinical features and it may be easily underdiagnosed unless it is suspected and thyroid hormone levels are examined." | ( Amasyalı, B; Barçın, C; Kılıç, A, 2011) |
| "Hyperthyroidism is characterized in rats by increased energy expenditure and marked hyperphagia." | ( Chatterjee, K; Diéguez, C; Gallego, R; Gándara, M; López, M; Martínez-Sánchez, N; Nogueiras, R; Roa, J; Schoenmakers, E; Tena-Sempere, M; Varela, L; Vázquez, MJ, 2012) |
| "Hyperthyroidism is associated with bone loss, which is reversible after treatment." | ( Dhanwal, DK; Gupta, N, 2011) |
| "Hyperthyroidism is associated with increased thrombosis risk, and fibrin clot structure determines susceptibility to vascular thrombotic events." | ( Ajjan, RA; Alzahrani, SH; Gerdes, VE; Hess, K; Hooper, JM; Orme, SM; Phoenix, F; Rice, P; Smith, KA; Standeven, KF; Stuijver, DJ; van Zaane, B, 2012) |
| "Endogenous hyperthyroidism is associated with more compact clots and resistance to fibrinolysis ex vivo, related to the degree of hyperthyroidism and C3 plasma levels, and these changes are modulated by achieving euthyroidism." | ( Ajjan, RA; Alzahrani, SH; Gerdes, VE; Hess, K; Hooper, JM; Orme, SM; Phoenix, F; Rice, P; Smith, KA; Standeven, KF; Stuijver, DJ; van Zaane, B, 2012) |
| "Hyperthyroidism is associated with unpleasant symptoms and hypertension due to increased adrenergic tone." | ( Eren, MA; Ozbilen, S; Sabuncu, T; Turan, MN, 2012) |
| "Hyperthyroidism is associated with increased food intake, energy expenditure and altered body composition." | ( Bhansali, A; Das, S; Dutta, P; Khandelwal, N; Masoodi, SR; Walia, R, 2012) |
| "Overt hyperthyroidism is present in less than 1% of pregnant women but is linked to increased rates of miscarriage, preterm delivery and maternal congestive heart failure." | ( Pearce, E; Stagnaro-Green, A, 2012) |
| "Hypothyroidism and hyperthyroidism are associated with maternal and neonatal pregnancy complications." | ( Bisschop, PH; Fliers, E; Goddijn, M; Mol, BW; van der Post, JA; Vissenberg, R, 2012) |
| "Hyperthyroidism is one of the most common endocrine disorders in pregnant women, and it can severely complicate the course and outcome of pregnancy." | ( Blichowski, M; Hackmon, R; Koren, G, 2012) |
| "Maternal hyperthyroidism is associated with alterations in fetal development and altered pattern of expression in RAS components, which in addition to cardiac hypertrophy observed on GD20 may represent an important predisposing factor to cardiovascular diseases in adult life." | ( Barreto-Chaves, ML; Lino, CA; Shibata, CE, 2014) |
| "Hyperthyroidism is the most common feline endocrinopathy." | ( Caney, SM, 2013) |
| "Hyperthyroidism is characterized by increased vascular relaxation and decreased vascular contraction and is associated with augmented levels of triiodothyronine (T3) that contribute to the diminished systemic vascular resistance found in this condition." | ( Barreto-Chaves, ML; Bruno-Fortes, Z; Carrillo-Sepúlveda, MA; Carvalho, MH; Ceravolo, GS; Furstenau, CR; Laurindo, FR; Monteiro, Pde S; Tostes, RC; Webb, RC, 2013) |
| "Hyperthyroidism is rare in pre-school children." | ( Cheetham, T; Dasarathi, M; Devlin, AM; Lodh, R; Sohal, AP, 2013) |
| "Subclinical hyperthyroidism is defined as a low TSH with both FT4 and free triiodothyronine (FT3) concentrations within range (2." | ( Chackathayil, J; Davis, RC; Gill, PS; Hughes, E; Lip, GY; Patel, JV; Webster, C, 2013) |
| "Hyperthyroidism is known to increase food intake and central administration of thyroid hormone shows acute orexigenic effects in rodents." | ( Dhanesha, N; Jain, MR; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V; Raval, P; Raval, S, 2014) |
| "Feline hyperthyroidism is commonly diagnosed in general practice." | ( Hibbert, A; Higgs, P; Murray, JK, 2014) |
| "Graves hyperthyroidism is commonly seen in clinical practice and Takotsubo stress cardiomyopathy is an increasingly recognized cardiac complication of physical or emotional stress." | ( Perkins, MJ; Schachter, DT, 2014) |
| "RAAS activation in hyperthyroidism is associated with increased VEGFCR; however, increased VEGFCR was not correlated with the development of aCKD." | ( Elliott, J; Syme, HM; Williams, TL, 2014) |
| "Hyperthyroidism is one of the most frequent endocrine disorders and its current treatment is based on drugs, surgery and radioactive iodine." | ( Forero, JD; López-P, Rdel P; Sierra, F, 2014) |
| "Subclinical hyperthyroidism is associated with increased left ventricular mass of the heart, which reverts after obtaining euthyroidism." | ( Faber, J; Selmer, C, 2014) |
| "Hyperthyroidism is a common endocrinopathy of geriatric cats, which are also prone to various other diseases." | ( Cattin, I; Puig, J; Seth, M, 2015) |
| "Hyperthyroidism is common in cats, but there are no reports that evaluate its severity or underlying thyroid tumor disease based on disease duration (ie, time from original diagnosis)." | ( Broome, MR; Peterson, ME; Rishniw, M, 2016) |
| "Neonatal hyperthyroidism is usually a self-limited condition frequently associated with transplacental passage of thyroid stimulating antibodies secondary to maternal autoimmune disorders." | ( Alvarado S, JL; Fernández V, ZA, 2014) |
| "Hyperthyroidism is associated with a significant increase in circulating glucocorticoid levels and hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis." | ( Calogero, AE; Chrousos, GP; Johnson, EO; Kamilaris, TC; Mytilinaios, D; Nikolopoulou, E; Troupis, T, 2015) |
| "Hyperthyroidism is a common disease that usually responds to the conventional therapy of anti-thyroidal medications (methimazole or PTU) and beta-blocker." | ( Alswat, KA, 2015) |
| "Hyperthyroidism is much less common in children <7 years vs." | ( Kaplowitz, P; Stafford, D; Vaidyanathan, P, 2015) |
| "Hyperthyroidism is a pathologic condition in which the body is exposed to excessive amounts of circulating thyroid hormones." | ( Aksu, O; Çanak, S; Çarlı, AB; Erkol İnal, E; Köroğlu, BK; Savaş, S, 2015) |
| "Hyperthyroidism is common in older cats, which necessitates frequent screening of serum total thyroxine (TT4) concentrations." | ( Archer, J; Williams, TL, 2016) |
| "Feline hyperthyroidism is a common endocrine disorder in older cats." | ( Ballhausen, BD; Hartmann, K; Köhler, I; Stockhaus, C; Wehner, A, 2016) |
| "Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source." | ( Braverman, LE; De Leo, S; Lee, SY, 2016) |
| "The risk of hyperthyroidism is related to the number of fetuses." | ( Bakas, P; Boutas, I; Creatsa, M; Hassiakos, D; Tzouma, C, 2016) |
| "Conclusions Hyperthyroidism is rare, whereas increased fPLI concentration, possibly reflecting pancreatitis, is common in diabetic cats." | ( Kooistra, HS; Prins, M; Reusch, CE; Riond, B; Schaefer, S; Steiner, JM; Suchodolski, JS; Zini, E, 2017) |
| "Hyperthyroidism is the most common feline endocrinopathy; thyroid computed tomography (CT) may improve disease detection and methimazole dose selection." | ( Bobe, G; Bush, JL; Gordon, J; Nemanic, S, 2017) |
| "Hyperthyroidism is a state of thyroid hormone excess, which increases the metabolic rate and causes symptoms including anxiety and tremor." | ( Kelley, S, 2016) |
| "Feline hyperthyroidism is a common endocrine disorder in older cats for which homeopathic treatment has been advocated." | ( Almond, CJ; Bodey, AL; Holmes, MA, 2017) |
| "Hyperthyroidism is a form of thyrotoxicosis in which there is excess thyroid hormone synthesis and secretion." | ( Hershman, JM; Singh, I, 2016) |
| "Hyperthyroidism is associated with increased thrombotic risk." | ( Gu, JY; Han, SE; Kim, ES; Kim, HK; Kim, N; Kim, YI; Nam-Goong, IS; Yoo, HJ, 2017) |
| "Hyperthyroidism is currently recognized to affect the cardiovascular system, leading to a series of molecular and functional changes." | ( Fogaça, RTH; Francisco, JC; Olivoto, RR; Silva, POD; Vieira, FF, 2016) |
| "Hyperthyroidism is associated with increased mortality in the aged, this dependent upon type and adequacy of treatment." | ( Duntas, LH, 2018) |
| "Subclinical hyperthyroidism is considered an independent risk factors for cardiovascular morbidity of patients with IHD." | ( Anselmino, M; Bonelli, N; Castagno, D; Gaita, F; Garberoglio, R; Ghigo, E; Grimaldi, R; Maccario, M; Parasiliti Caprino, M; Rossetto, R; Vignolo, F, 2018) |
| "Hypo and hyperthyroidism are the second most prevalent endocrine disease worldwide." | ( Bargi-Souza, P; Nunes, MT; Peliciari-Garcia, RA; Young, ME, 2018) |
| "Hyperthyroidism, is less frequent in this clinical context but it necessitates of immediate treatment because of its negative effects on cardiovascular balance." | ( Gioia, MI; Iacoviello, M; Parisi, G; Rizzo, C; Triggiani, V, 2018) |
| "Hyperthyroidism is known to cause endothelial dysfunction, alterations in coagulation, and fibrinolytic pathways favoring hypercoagulable state." | ( Acharya, D; Hornbuckle, L; Joly, J; Pamboukian, S; Rajapreyar, I; Sharpton, J; Tallaj, J, 2019) |
| "Hypothyroidism and hyperthyroidism are common conditions with potentially devastating health consequences that affect all populations worldwide." | ( Albrecht, D; Dayan, CM; Gutierrez-Buey, G; Lazarus, JH; Okosieme, OE; Scholz, A; Taylor, PN, 2018) |
| "Amiodarone-induced hyperthyroidism is a known side effect of amiodarone treatment." | ( Bertsche, A; Gebauer, R; Gesing, J; Hoppmann, J; Kiess, W; Pfäffle, R, 2018) |
| "Hyperthyroidism is the result of uncontrolled overproduction of the thyroid hormones." | ( Ali, SA; Awad, SM; Mahgoub, S; Said, AM; Zohny, YM, 2018) |
| "Although hyperthyroidism is associated with high turnover osteopenia and its recovery after treatment, the extent of recovery with different forms of therapy remains controversial." | ( Asokumar, P; Chockalingam, R; Karunakaran, P; Koramadai Karuppusamy, K; Maharajan, C; Sadasivam, V, 2019) |
| "The underlying hyperthyroidism is often subtle without typical symptoms such as palpitations, tremors, anxiety, and weight loss; this causes a difficulty in early diagnosis." | ( Liu, KT; Wang, PH; Wu, YH; Yeh, IJ, 2018) |
| "Hyperthyroidism is an endocrine disorder characterized by excessive secretion of thyroid hormones T3 and T4." | ( Barreiro Arcos, ML; Costilla, M; Cremaschi, GA; Klecha, A; Macri Delbono, R, 2019) |
| "Feline hyperthyroidism is the most commonly diagnosed endocrine-related disease among senior and geriatric housecats, but the causes remain unknown." | ( Anderson, KA; Gonzalez, D; Gordon, J; Herbstman, JB; Holmes, D; Peterson, ME; Poutasse, CM; Soboroff, PH; Tidwell, LG, 2019) |
| "Subclinical hyperthyroidism is defined by a subnormal serum thyroidstimulating hormone (TSH) level with normal free thyroxine (FT4) and free triiodothyronine (FT3) levels." | ( De Luca, G; Di Stolfo, G; Maggio, A; Massaro, R; Mastroianno, S; Pacilli, M; Potenza, DR; Russo, A, 2020) |
| "Hyperthyroidism is a common endocrinopathy of middle-aged and elderly cats." | ( Biagi, G; Bubini-Regini, F; Fracassi, F; Grossi, G; Leoni, N; Malerba, E; Palagiano, P; Peli, A; Zoia, A, 2019) |
| "Amiodarone induced hyperthyroidism is divided into two subtypes, which differ by mechanism of origin and treatment strategy." | ( Brutvan, T; Ježková, J; Krátký, J, 2020) |
| "Hyperthyroidism is a significant contributor to oxidative stress in patients with active TAO, which manifests as upregulated lipid peroxidation and antioxidant system activation." | ( Kos-Kudła, B; Londzin-Olesik, M; Nowak, A; Nowak, M; Wielkoszyński, T, 2020) |
| "Furthermore, hyperthyroidism is also linked with a poorer cancer prognosis." | ( Giovanella, L; Hoffmann, M; Iakovou, I; Luster, M; Mihailovic, J; Petranović Ovčariček, P; Verburg, FA; Vrachimis, A, 2021) |
| "Hyperthyroidism is associated with low levels of cholesterol and triglycerides, and hypothyroidism is associated with hypercholesterolemia and hypertriglyceridemia." | ( Alahdab, F; Cortes, T; Genere, N; Hamidi, O; Jasim, S; Kotwal, A; Murad, MH; Newman, CB; Prokop, LJ, 2020) |
| "Hyperthyroidism is a condition in which the thyroid gland is overreactive and produces excess amounts of thyroid hormone." | ( Gao, J; He, C; Jia, S; Xie, C, 2020) |
| "Hyperthyroidism is a set of disorders that involve excess synthesis and secretion of thyroid hormones by the thyroid gland, which leads to thyrotoxicosis." | ( Barczyński, M, 2021) |
| "Hyperthyroidism is associated with results in increased glomerular filtration rate as well as increased renin-angio- tensin-aldosterone activation." | ( Bağcı, R; Bektur Aykanat, NE; Burukoğlu Dönmez, D; Kaçar, S; Karakaya, Ş; Şahin, E; Şahintürk, V, 2021) |
| "Central hyperthyroidism is a rare form of hyperthyroidism caused by thyrotrope pituitary adenomas." | ( Cummings, T; Jackson, DG; Parker, J, 2021) |
| "Hyperthyroidism is a common disease mainly manifested by hyperexcitability of multiple systems and hypermetabolism." | ( Xu, HX; Yu, SY; Zhang, HL; Zhu, JE, 2021) |
| "Hyperthyroidism is characterized by abnormal thyroid stimulating immunoglobulin (TSI) which causes low TSH and high FT4 levels." | ( Hanim, D; Harjantini, U; Nurwati, I; Retno Dewi, YL, 2021) |
| "Hyperthyroidism is characterized by increasing production of thyroid hormone (TH) and decreasing of thyroid stimulation hormone (TSH) secretion." | ( Al-Shorman, A; Alhilo, I; Alhilo, S; Alkhatib, B, 2021) |
| "Neonatal hyperthyroidism is an extension of fetal disease." | ( Fan, L; Gao, Y; Hou, X; Li, L; Peng, C; Sun, W; Zhang, X, 2022) |
| "Hyperthyroidism is a common endocrinopathy of domestic felines." | ( Alborough, R; Gardner, DS; Graham, PA, 2022) |
| "Hyperthyroidism is a rare complication after HSCT but may affect healthy and lead to lower quality of life." | ( Ding, L; Han, DM; Liu, J; Wan, HX; Xiao, L; Xue, M; Yan, HM; Zhang, D; Zheng, XL; Zhu, L, 2022) |
| "Hyperthyroidism is associated with cardiac hypertrophy, fibrosis, and increased risk of cardiovascular mortality." | ( Abdullah, DM; Alsemeh, AE; Khamis, T, 2022) |
| "Hyperthyroidism is not associated with radiographic pulmonary hyperinflation and is an unlikely differential for this radiographic finding." | ( Marolf, AJ; Rao, S; Shropshire, SB; Young, V, 2022) |
| "Iatrogenic hyperthyroidism is common among infants with primary CH when treated with the recommended LT4 dosage." | ( Chooprasertsuk, N; Dejkhamron, P; Unachak, K; Wejaphikul, K, 2022) |
| "Hyperthyroidism is associated with a number of heart diseases, and it may aggravate previous cardiac problems or cause new ones, such as hyperthyroid cardiopathy." | ( Lu, DC; Meng, XL; Miao, CQ; Wang, WY; Zhao, Y, 2022) |
| "Hyperthyroidism is characterized by increased thyroid hormone production, which impacts various processes, including metabolism and energy expenditure." | ( Abdel Rahman, AM; Alfadda, AA; AlMalki, RH; Benabdelkamel, H; Dahabiyeh, LA; Jaber, MA; Masood, A; Musambil, M, 2022) |
| "Hyperthyroidism is characterized by increased thyroid hormone production, which impacts various processes, including metabolism and energy expenditure." | ( Abdel Rahman, AM; Alfadda, AA; AlMalki, RH; Benabdelkamel, H; Dahabiyeh, LA; Jaber, MA; Masood, A; Musambil, M, 2022) |
| "If factitious hyperthyroidism is suspected, we should request thyroglobulin and anti-thyroglobulin tests, as well as a thyroid scan or uptake curve." | ( Cristabel Rubino, G; Kozak, A; Lovazzano, S; Ortiz, MI; Scheinfeld, G; Varsavsky, M, 2022) |
| "Hyperthyroidism is a common endocrine disorder which leads to higher resting energy expenditure (REE)." | ( Betz, MJ; Bur, F; Fischer, JGW; Löliger, RC; Maushart, CI; Senn, JR, 2022) |
| "Hyperthyroidism is a catabolic state related to increased energy consumption, protein turnover, and lipolysis." | ( Aadim, KA; Ahmed, KA; Mohammed, RS, 2023) |
| "Hyperthyroidism is a health problem characterized by an overactive thyroid gland, resulting in extra triiodothyronine (T3) and thyroxine (T4) production, as well as a decrease in thyroid-stimulating hormone (TSH)." | ( Al-Abady, ZN; Al-Athary, RAH; Jasib Thaaban Almzail, A; Khinteel Jabbar, N, 2022) |
| "BACKGROUND Hyperthyroidism is an overproduction of thyroid hormones." | ( AlAboud, M; Alanizi, A; Alasqah, MA; Alhubaishi, AA; Alkahtani, R; Alnajjar, LI; Alwahhabi, B; Bin Sheraim, N, 2023) |
| "Hyperthyroidism is an endocrine disease caused by improper continuous synthesis and secretion of excessive thyroid hormone by the thyroid gland." | ( Dong, WY; He, LM; Liu, M; Sun, XL, 2023) |
| Excerpt | Reference |
|---|
| "55 patients with treated hyperthyroidism (thyreostatics) underwent a T3 suppression test and a TRH stimulation test." | ( Gauer, J; Gottschild, D; Heberling, HJ; Heilmann, W; Löbe, J; Müller, G, 1977) |
| "The major drawback to treatment of hyperthyroidism with antithyroid compounds is the reported low rate of remission." | ( Burrows, BA; Slingerland, DW, 1979) |
| "Serial studies to follow the effects of treatment of hyperthyroidism on red cell membrane ATPase were performed repeatedly in one of these patients." | ( Cole, CH; Waddell, RW, 1976) |
| "The possibilities of the treatment of hyperthyroidism are mentioned, in which cases the author especially deals with the medicamentous therapy, taking into consideration the different chemical groups (imidazol derivations, thiourazil derivations, perchlorates) and their therapeutic mechanisms." | ( Gauer, J; Heberling, HJ; Lohmann, D, 1976) |
| "However, in patients treated for hyperthyroidism a hyper-response to glucagon can continue after blood levels of thyroid hormones are reduced to normal." | ( Madsen, SN, 1977) |
| "Lymphocytes from 12 patients with untreated hyperthyroidism were compared to lymphocytes from age- and sex-matched euthyroid control subjects to test the hypothesis that alterations in beta-adrenergic response mechanisms occur in human hyperthyroidism." | ( Guthrow, CE; Lefkowitz, RJ; Williams, RS, 1979) |
| "A group of 96 patients suffering from untreated hyperthyroidism (85 women and 11 men) was studied (79 of these patients were also followed during treatment) and compared to a control group of 157 persons (107 women and 50 men)." | ( Friis, T; Linde, J, 1979) |
| "In untreated hyperthyroidism a significant decrease was found in both BMC and BMC'." | ( Charles, P; Mosekilde, L; Nielsen, HE, 1979) |
| "After treatment of hyperthyroidism the MCV rose in these patients by an average of 6 fl." | ( Himsworth, RL; Nightingale, S; Vitek, PJ, 1978) |
| "Finally, iodides do have a role in the treatment of hyperthyroidism but their use should probably be restricted to thyroid storm, preoperative preparation of the hyperthyroid patient, and following 131I treatment." | ( Braverman, LE; Vagenakis, AG, 1975) |
| "We described the effect of untreated hyperthyroidism on Na+K+ATPase activity, ouabain binding sites and intracellular sodium concentration." | ( Chen, S; De Riva, C; Frigato, F; Virgili, F, 1992) |
| "Improved values were seen after treatment for hyperthyroidism although statistical significance was not reached." | ( Behera, D; Dash, RJ; Jindal, SK; Roy, R, 1992) |
| "After treatment of hyperthyroidism, serum EGF returned to the normal levels (232 +/- 176 pmol/l)." | ( Hui, WM; Kung, AW; Ng, ES, 1992) |
| "In the patients with untreated hyperthyroidism, t1/2t was significantly reduced (22." | ( Iversen, E, 1991) |
| "Patients included 42 adults with untreated hyperthyroidism (FT4 greater than 25 pmol/l; TSH less than 0." | ( Amit, T; Hertz, P; Hochberg, Z; Ish-Shalom, S; Lotan, R; Luboshitzki, R; Youdim, MB, 1991) |
| "Similar effects were observed after T4-treatment, but hyperthyroidism induced disproportionate increases in energy expenditure (+7%), plasma glycerol (+310%), and ketone body levels (+436%)." | ( Acheson, KJ; Burger, AG; Jequier, E; Müller, MJ, 1990) |
| "Early detection and treatment of feline hyperthyroidism presents an obvious advantage in avoiding some of the deleterious effects of chronic thyroid hormone excess (eg, cardiomyopathy)." | ( Graves, TK; Peterson, ME, 1990) |
| "Data of 196 patients treated for hyperthyroidism exclusively with antithyroid drugs were analyzed retrospectively concerning the relapse rate within a follow-up period of four years." | ( Dickmann, N; Emrich, D; Schicha, H; Voth, E, 1990) |
| "After treatment of hyperthyroidism, the neurological symptoms disappeared." | ( Corominas Torres, JM; Lloreta Trull, J; Oliva Bielsa, J; Pou Serradell, A; Roquer Gonzalez, J; Ugarte Elola, A, 1990) |
| "After successful treatment of hyperthyroidism, SHBG levels normalized in patients with nIST, but they did not change in patients with nnIST." | ( Beck-Peccoz, P; Brabant, G; Faglia, G; Forloni, F; Marcocci, C; Mariotti, S; Medri, G; Pinchera, A; Roncoroni, R, 1990) |
| "The mean [Na+]i value in the untreated hyperthyroidism group was significantly higher than that in the normal subjects (p less than ." | ( Bang, BK; Cha, BY; Hong, KS; Kang, SK; Kim, YW; Lee, KW; Moon, HR; Son, HY; Yoon, YS, 1989) |
| "With appropriate treatment of hyperthyroidism and hypothyroidism, the levels of the three peptides returned to normal." | ( Sallman, AL; Vesely, DL; Winters, CJ, 1989) |
| "Fasting C-peptide was reduced in untreated hyperthyroidism (0." | ( Beer, SF; Hales, CN; Parr, JH; Temple, RC, 1989) |
| "We studied the effects of radioiodine treatment of hyperthyroidism due to Graves' disease on Graves' ophthalmopathy and the possible protective role of corticosteroids." | ( Bartalena, L; Bogazzi, F; Lepri, A; Marcocci, C; Panicucci, M; Pinchera, A, 1989) |
| "It recovered after treatment of hyperthyroidism." | ( Erfurth, EM; Hedner, P, 1988) |
| "Proteinuria decreased during treatment of hyperthyroidism with an antithyroid drug." | ( Akashi, K; Iidaka, K; Inage, Z; Iwamori, M; Kikkawa, Y; Kitagawa, T; Matsuura, M; Serisawa, T; Takimoto, T, 1987) |
| "Chorea resolved with treatment of hyperthyroidism." | ( Ahronheim, JC, 1988) |
| "We use an antithyroid drug for the treatment of hyperthyroidism due to Graves' disease in children and adolescents for as long as the patients are willing to comply and/or tolerate the drug." | ( Kaplan, SA; Landaw, EM; Lippe, BM, 1987) |
| "In the patients with untreated hyperthyroidism, values for all these functions were greatly increased." | ( Ingbar, SH; Sobel, RJ; Sterling, K; Woeber, KA, 1970) |
| "There is extensive experience in the treatment of hyperthyroidism with beta-blockade." | ( Adam, RD; Harrower, AD; Parekh, P, 1981) |
| "A total of 225 patients were treated for hyperthyroidism with 555 MBq (15 mCi) radioiodine to ablate the thyroid and induce early hypothyroidism." | ( Keir, MJ; Kendall-Taylor, P; Ross, WM, 1984) |
| "Previous unsuccessful treatments for hyperthyroidism included hemithyroidectomy (2 cats) and an antithyroid drug (7 cats)." | ( Feldman, EC; Hays, M; Hornof, WJ; Turrel, JM, 1984) |
| "Eleven pregnant women were treated for hyperthyroidism with carbimazole (CZ) and one with propylthiouracil (PTU)." | ( Ikonen, E; Lamberg, BA; Osterlund, K; Pekonen, F; Peltola, J; Teramo, K; Välimäki, M, 1984) |
| "Serum TBPA levels in patients with untreated hyperthyroidism were 12." | ( Hachiya, T; Ijichi, H; Ishida, M; Kajita, Y; Miyazaki, T; Ochi, Y; Yoshimura, M, 1982) |
| "In patients being treated for either hyperthyroidism or hypothyroidism, the serum TSH level appeared to be a sensitive indicator of thyroid status, and its return to normal appeared to be a useful therapeutic criterion." | ( Nisula, BC; Pugeat, MM; Rubenstein, HA; Wehmann, RE, 1983) |
| "In patients with untreated hyperthyroidism, aldosterone response was similar to that in normal subjects." | ( Ieiri, T; Kasai, K; Naitoh, T; Nakamura, T; Shimoda, S; Shina, H; Suzuki, H; Takemura, Y, 1980) |
| "In untreated hyperthyroidism, there was a decreased sensitivity to the antilipolytic effect of insulin, since the dose-response curve was shifted to the right; 250 microU/ml insulin were required for 50% of the maximal effect compared to 25 microU/ml in the controls." | ( Arner, P; Ostman, J; Wennlund, A, 1981) |
| "Following treatment of hyperthyroidism by surgery, antithyroid drugs or radioiodine, there was a significant rise in the plasma propranolol Css in patients receiving propranolol either 160 mg/day, 240 mg/day, or 480 mg/day." | ( Crooks, J; Feely, J; Stevenson, IH, 1981) |
| "The values of Mb in untreated hyperthyroidism were significantly lower (P<0." | ( Kasai, K; Shimoda, SI, 1980) |
| "Untreated or poorly treated hyperthyroidism may present a clinical picture similar to preeclampsia." | ( Baucom, D; Mayer, DC; Spielman, FJ; Thorp, J, 1995) |
| "Sixteen patients with untreated hyperthyroidism due to Graves' disease (8 female and 8 male), with a mean age (+/- SE) of 31." | ( Ciccarelli, E; Grottoli, S; Portioli, I; Razzore, P; Valcavi, R; Zini, M, 1994) |
| "We studied 19 subjects with untreated hyperthyroidism, 12 hyperthyroid subjects sampled at 4-week intervals after beginning carbimazole, 153 subjects receiving T4 replacement, and 300 hospital in-patients with a variety of NTIs." | ( Betteridge, J; Black, EG; Franklyn, JA; Sheppard, MC, 1994) |
| "Our results demonstrate that 131I treatment for hyperthyroidism may seriously damage thyroid C-cells and cause calcitonin deficiency." | ( Georgiadis, G; Nikou, A; Philokiprou, D; Thalassinos, NC; Tzanela, M, 1993) |
| "A woman treated for hyperthyroidism is described." | ( Bergmann, P; Karmali, R; Mirkine, N, 1993) |
| "Propylthiouracil is widely used in the treatment of hyperthyroidism." | ( Akyol, G; Alkim, H; Boztepe, U; Cakir, N; Kandílć, U; Ozenírler, S; Tuncer, C, 1996) |
| "Thirty cats with untreated hyperthyroidism were blood sampled and their calcium homeostatic mechanisms and renal function assessed." | ( Barber, PJ; Elliott, J, 1996) |
| "In contrast, treatment of hyperthyroidism was associated with an increase in total and HDL cholesterol, and apo AI." | ( Hay, ID; Hodge, D; Katz, K; Kottke, BA; Nguyen, TT; O'Brien, T, 1997) |
| "Chronic triiodothyronine (T3) treatment (hyperthyroidism) increased the interscapular BAT pad weight, its triacylglycerol content, and its DNA content." | ( Kuroshima, A; Ohinata, H; Ohno, T; Saha, SK, 1998) |
| "As adjunctive COL treatment in hyperthyroidism allows reducing MMI dosage it may decrease the rate of dose dependent MMI side effects." | ( Hagag, P; Nissenbaum, H; Weiss, M, 1998) |
| "We conclude that weight gain following treatment of hyperthyroidism is due to 1) reduction in metabolic rate consequent upon the decreased thyroid hormone concentrations and 2) food energy intake which was initially greater than required to maintain individuals' premorbid weight." | ( Abid, M; Billington, CJ; Nuttall, FQ, 1999) |
| "Whenever beta-blockers are chosen for treatment of hyperthyroidism, propranolol (beta 1 + beta 2) has an advantage because it reduces the metabolic rate, whereas selective beta 1-blockade seemed to provide only symptomatic relief, related to the normalization of heart rate." | ( Jansson, S; Körner, U; Lie-Karlsen, K; Lundholm, K; Stenqvist, O; Tisell, LE, 2001) |
| "917 cats with untreated hyperthyroidism, 221 cats with nonthyroidal disease, and 172 clinically normal cats." | ( Melián, C; Nichols, R; Peterson, ME, 2001) |
| "In patients with untreated hyperthyroidism, a significant shortening of PEP, PEPI, LVET and low PEP/LVET index and TPRI as well as increased LVSF, LVEF, mVcf, CIx, CI, OPI and DP were shown." | ( Jonderko, G; Kucharz, EJ; Marcisz, C; Wojewódka, J, 2001) |
| "Surgery seems to be the radical treatment when hyperthyroidism doesn't respond to the medical treatment and when the cardiopathy requires amiodarone." | ( Carlioz, R; Chollet, O; Dariel, MP; Gouteyron, JF; Hervé, S; Leyral, H; Perrier, E, 2001) |
| "A patient with a properly treated hyperthyroidism can safely undergo dental treatment, although periods of stress are to be avoided." | ( Asscheman, H; Gortzak, RA, 1996) |
| "Information from the history (previous treatment for hyperthyroidism, age), physical examination (sex, body weight), routine plasma biochemical analyses (creatinine, cholesterol, potassium, sodium, chloride, and calcium concentrations), and thyroid status were evaluated as potential risk factors for systolic hypertension." | ( Barber, PJ; Elliott, J; Markwell, PJ; Syme, HM, 2002) |
| "Establishment of radioiodine treatment of feline hyperthyroidism in veterinary routine in accordance with German radiation protection regulations." | ( Bauer, R; Grünbaum, EG; Knietsch, M; Puille, M; Spillmann, T, 2002) |
| "A proper, first-line treatment of hyperthyroidism will prevent the deterioration of primary hyperparathyroidism course, and thus surgical parathyroid treatment may safely be introduced." | ( Bednarek, J; Bolko, P; Jaskuła, M; Sowiński, J; Waśko, R, 2003) |
| "Two-thirds of patients with treated hyperthyroidism died." | ( Bernard, W; Feldkamp, J; Horster, FA; Kovács, G; Radácsi, A; Szabolcs, I, 2003) |
| "Percutaneous heat ablation as a treatment for hyperthyroidism in cats is effective transiently but not permanently." | ( Feldman, EC; Hornof, WJ; Mallery, KF; Nelson, RW; Pollard, RE, 2003) |
| "One hundred and one patients with untreated hyperthyroidism were randomly divided into two sex and age-matched groups: group A (n = 45, consuming pure salt without iodine) and group B (n = 56, consuming iodated salt)." | ( Dai, WX; Li, SH; Li, SM; Li, XW; Lian, XL; Lu, L, 2003) |
| "A 35-year-old Asian male, treated for hyperthyroidism, systemic lupus erythematosis, and uremia presented with low serum total thyroxine (T4) and normal serum thyrotropin (TSH) levels." | ( Kaptein, EM; Nelson, JC; Wilcox, RB, 2004) |
| "Patients with subclinical and treated overt hyperthyroidism have an excess vascular mortality rate." | ( Chowdhary, S; Daykin, J; Franklyn, JA; Gammage, MD; Holder, RL; Osman, F; Sheppard, MC, 2004) |
| "Long-term continuous treatment of hyperthyroidism with MMI is safe." | ( Ataie, L; Azizi, F; Hedayati, M; Mehrabi, Y; Sheikholeslami, F, 2005) |
| "Radioiodine is an effective and safe treatment for hyperthyroidism but has been implicated as a risk factor for deterioration or new presentation of Graves' ophthalmopathy (GO)." | ( Dickinson, J; Frewin, S; Kendall-Taylor, P; Neoh, C; Perros, P, 2005) |
| "This supports treating hyperthyroidism with doses of radioiodine sufficient to induce overt hypothyroidism." | ( Franklyn, JA; Maisonneuve, P; Sheppard, MC, 2005) |
| "Forty-five patients were treated for active hyperthyroidism, 161 were euthyroid (85 immediately before withdrawal of antithyroid drug at maintenance doses, 76 in stable remission after withdrawal of antithyroid treatment)." | ( Baldini, M; Bonfanti, MT; Cantalamessa, L; Castagnone, D; Orsatti, A, 2005) |
| "Radioiodine used for the treatment of hyperthyroidism improved the symptoms of myasthenia gravis in the first patient." | ( Abid, M; Charfi, N; Mhiri, Ch; Mnif, M; Rekik, N; Trabelsi, L; Triki, Ch, 2006) |
| "Discontinuation of methimazole and treatment of hyperthyroidism with lithium followed by radioactive iodine therapy resulted in resolution of his symptoms." | ( Babu, A; Majeed, M, 2006) |
| "KD has good efficacy in treating hyperthyroidism, and the combined treatment of Chinese and Western medicine shows obvious advantages." | ( Fan, J; Yang, HJ; Zheng, M, 2006) |
| "Radioiodine-131 is commonly used for treatment of hyperthyroidism but there are few available data on the effects of this treatment on male gonadal function." | ( Battisti, P; Caglieresi, C; Canale, D; Ceccarelli, C; Fiore, E; Grasso, L; Moschini, C; Pinchera, A; Vitti, P, 2006) |
| "It has proved efficacy in the treatment ofhyperthyroidism, porphyria, cirrhosis, migraine and in the therapy of many neuropsychiatric disorders." | ( Olakowska, E; Olakowski, M, 2006) |
| "Propylthiouracil is a drug used in the treatment of hyperthyroidism for more than 60 years." | ( Atilgan, KG; Ayli, MD; Dede, F; Duranay, M; Guler, S; Memis, L; Yuksel, A; Yuksel, C, 2007) |
| "Melatonin treatment during hyperthyroidism normalized aconitate hydratase activity and citrate concentration." | ( Pashkov, AN; Popov, SS; Popova, TN; Rakhmanova, TI; Semenikhina, AV; Zoloedov, VI, 2007) |
| "We hypothesized that treatment of hyperthyroidism may have different effects on glomerular and tubular function and these changes might be predicted by additional pre-treatment variables than GFR." | ( Binst, D; Croubels, S; Daminet, S; Kooistra, H; Lefebvre, HP; Meyer, E; Peremans, K; Saunders, JH; van Hoek, I; Vandermeulen, E, 2009) |
| "A decrease in resting heart rate in untreated hyperthyroidism due to verapamil treatment did not result in decreasing N-terminal-pro-B-type natriuretic peptide levels." | ( Andersen, HU; Corell, P; Faber, J; Jarlov, A; Kistorp, C; Schultz, M, 2009) |
| "After adequately treating the hyperthyroidism, basal cortisol levels in both patients returned to the reference range." | ( Burman, KD; Cole, J; Golding, J; Karl, M; Onumah, BM; Wartofsky, L, 2009) |
| "These studies demonstrate that untreated hyperthyroidism is associated with elevated CgA level that changes in parallel to thyroid status." | ( Al-Shoumer, KA; Vasanthy, BA, 2009) |
| "Thirty patients with untreated hyperthyroidism and 25 age- and sex-matched healthy controls were included in the study." | ( Erem, C; Ersoz, HO; Kocak, M; Nuhoglu, İ; Ucuncu, O; Yilmaz, M, 2009) |
| "The aim of treating hyperthyroidism in pregnancy with antithyroid drugs is to maintain serum thyroxine (T(4)) in the upper normal range of the assay used with the lowest possible dose of drug, whereas in hypothyroidism, the goal is to return serum thyroid-stimulating hormone (TSH) to the range between 0." | ( Davies, TF; Galofre, JC, 2009) |
| "Our protocol effectively treated hyperthyroidism and significantly reduced the hypothyroidism rate." | ( Chen, DY; Chen, TH; He, ZM; Jing, J; Schneider, PF; Zhang, XS, 2011) |
| "Anti-thyroid drugs (ATD) used to treat hyperthyroidism can cause agranulocytosis." | ( Dybowska, D; Halota, W; Karwowska, K; Kozielewicz, D, 2012) |
| "A 28-year-old woman with PTU-treated hyperthyroidism presented with fever, purpura, pulmonary cavitations and ANCA to myeloperoxidase, bactericidal/permeability-increasing protein (BPI), proteinase-3 and elastase." | ( Bonaci-Nikolic, B; Kontic, M; Nikolic, M; Radovanovic, S, 2012) |
| "GD patients with untreated hyperthyroidism had higher CXCL9 or CXCL11 than hyperthyroid or euthyroid GD patients under methimazole (MMI) treatment." | ( Antonelli, A; Corrado, A; Fallahi, P; Ferrannini, E; Ferrari, SM, 2013) |
| "A total of 30 untreated overt hyperthyroidism patients, 17 euthyroid congenital hypothyroidism children, and age- and sex-matched controls were enrolled." | ( Bai, F; Cheng, JP; Jin, Y; Ma, SG; Xu, W; Yue, HN, 2013) |
| "The recognition and treatment of fetal hyperthyroidism are believed to be important to optimize growth and intellectual development in affected fetuses." | ( Ikenoue, S; Ishii, T; Kadohira, I; Kasuga, Y; Matsumoto, T; Minegishi, K; Miyakoshi, K; Momotani, N; Saisho, Y; Sato, S; Yoshimura, Y, 2013) |
| "After appropriate pharmacologic treatment of her hyperthyroidism, she had complete resolution of her cardiomyopathy." | ( Perkins, MJ; Schachter, DT, 2014) |
| "Nearly 80% of responders do not treat subclinical hyperthyroidism in pregnancy." | ( Akamizu, T; Alamdari, S; Amouzegar, A; Azizi, F; Mehran, L; Poppe, K; San Luis, T; Sarvghadi, F; Subekti, I; Vaidya, B, 2014) |
| "Eprotirome treatment, but not hyperthyroidism, reduced plasma triglycerides." | ( Angelin, B; Bonde, Y; Breuer, O; Lütjohann, D; Rudling, M; Sjöberg, S, 2014) |
| "The treatment of THPP consists of treating for hyperthyroidism plus propranolol." | ( Eustatia-Rutten, CF; Kelderman, N; Kwak, AR; Piekaar, RS, 2014) |
| "After treatment of fetal hyperthyroidism through oral maternal administration of methimazole (MMI) starting at 33 weeks gestation, fetal heart rate and amniotic fluid volume returned to normal ranges." | ( Hayashi, S; Ishii, K; Mitsuda, N; Murata, M; Sasahara, J; Sato, Y, 2014) |
| "Propylthiouracil is a drug used to treat hyperthyroidism." | ( Costa, T; Ferreira, C; Marques, AV, 2015) |
| "Maternal treatments of hyperthyroidism include antithyroid medications such as methimazole and more commonly propylthiouracil (PTU)." | ( Curtis, J; Evans, MI; Felig, P; Kessler, AA; Munoz, JL, 2016) |
| "Patients managed on ATDs for the treatment of hyperthyroidism should be counseled to report a pregnancy as early as possible." | ( Andersen, SL, 2017) |
| "Low-dose radioiodine is effective treatment for hyperthyroidism in most cats but overt hypothyroidism may develop in some." | ( Finch, NC; Hibbert, A; Stallwood, J; Tasker, S, 2019) |
| "The oral treatment of feline hyperthyroidism with antithyroid drugs often results in gastrointestinal side effects (10-20%)." | ( Böhm, D; Haag, R; Kloner, L; Kohn, B; Moré, M; Moré, S; Volkmann, M, 2020) |
| "Radioiodine (RAI) treatment for hyperthyroidism is a very common modality, chosen by physicians worldwide." | ( Budlewski, T; Franek, E; Gryn, T; Kałuża, B; Stachura, A, 2020) |
| "Options for treatment of hyperthyroidism include: antithyroid drugs, radioactive iodine therapy (the preferred treatment of hyperthyroidism among US thyroid specialists), or thyroidectomy." | ( Barczyński, M, 2021) |
| "We described a successful treatment of hyperthyroidism patient with dietary-herbal supplementation with wet cupping without any medicine." | ( Al-Shorman, A; Alhilo, I; Alhilo, S; Alkhatib, B, 2021) |
| "Cats being treated for hyperthyroidism had lower hair iodine." | ( Alborough, R; Gardner, DS; Graham, PA, 2022) |
| "Early detection and treatment of hyperthyroidism, which can further elevate the risk of both of these diseases is therefore required." | ( Frank-Raue, K; Raue, F, 2023) |